Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV study of adsorbed tetanus vaccine immunogenicity and safety in people aged 16 years and older
ChiCTR2300071270Phase 4Not yet recruiting
- Sponsor
- Guizhou Provincial Center for Disease Control and Prevention
- Start
- May 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Tetanus Vaccine (Adsorbed) in Tetanus, sponsored by Guizhou Provincial Center for Disease Control and Prevention. Planned start May 2023; status: not yet recruiting.
02
Drugs
Tetanus Vaccine (Adsorbed)
03
Conditions
Tetanus
Beyond the preview
Go deeper on ChiCTR2300071270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071270.